Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases

• Egile Nagusiak: Paolo Gelosa (Egilea), Francesca Colazzo (Egilea), Elena Tremoli (Egilea), Luigi Sironi (Egilea), Laura Castiglioni (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2017-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Cysteinyl leukotrienes (CysLTs) are potent lipid mediators widely known for their actions in asthma and in allergic rhinitis. Accumulating data highlights their involvement in a broader range of inflammation-associated diseases such as cancer, atopic dermatitis, rheumatoid arthritis, and cardiovascu...